GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Endoscopy/Blown-Out Myotomy (BOM)

Blown-Out Myotomy (BOM)

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated September 1, 2025

Quick Answer

**Blown-Out Myotomy (BOM):** Blown-Out Myotomy (BOM) is a relatively rare but significant complication that can occur after undergoing Peroral Endoscopic Myotomy (POEM), a minimally invasive procedure used to treat esophageal motility disorders such as achalasia. Here is a detailed explanation of BOM based on the provided context: --- ### **Incidence of BOM:** - BOM was observed in **4.


**Blown-Out Myotomy (BOM):**

Blown-Out Myotomy (BOM) is a relatively rare but significant complication that can occur after undergoing Peroral Endoscopic Myotomy (POEM), a minimally invasive procedure used to treat esophageal motility disorders such as achalasia. Here is a detailed explanation of BOM based on the provided context:

---

### **Incidence of BOM:**

  • BOM was observed in **4.7% of patients** (28 out of 598) who underwent POEM during the study period.
  • While the overall incidence is low, it remains a notable complication requiring attention.

---

### **Timeline of BOM Progression:**

  • The development of BOM typically occurs within **1 to 3 years** after the POEM procedure.
  • After this initial period, the condition tends to **stabilize**, suggesting that the risk of progression decreases over time.

---

### **Risk Factors for BOM:**

Certain factors were found to significantly increase the risk of developing BOM:

1. **Male Sex**: Males were more likely to develop BOM than females.

2. **Thinner Esophageal Muscle Layers**: Patients with thinner esophageal muscle layers at the time of the myotomy were at higher risk.

3. **Presence of Clinical Reflux**: The occurrence of clinical reflux following the POEM procedure was strongly associated with BOM development.

These risk factors highlight the importance of careful patient selection and monitoring, as well as tailoring the POEM procedure to individual anatomical and clinical characteristics.

---

### **Severity Classification of BOM:**

  • BOM is defined by **diverticular-like changes** in the esophagus, which can vary in severity.
  • Grades 2 and 3 BOM, characterized by **obvious diverticular changes** that may sometimes include **food retention**, are categorized as **endoscopic BOM**. These cases are more severe and are likely to require closer monitoring and management.

---

### **Clinical Implications:**

  • While BOM is relatively uncommon, it is an **important complication** that can significantly impact a patient's quality of life.
  • Patients with identified risk factors (e.g., male sex, thin muscle layers, clinical reflux) are at higher risk, emphasizing the need for **personalized treatment plans** and **long-term surveillance** after POEM.

---

### **Key Takeaways:**

  • BOM is a rare but significant complication of POEM, with a 4.7% incidence rate.
  • It typically develops within 1-3 years post-POEM and then stabilizes.
  • Risk factors include male sex, thinner esophageal muscle layers, and post-POEM clinical reflux.
  • The severity of BOM can range from mild to severe, with Grades 2 and 3 requiring particular attention.
  • Long-term follow-up is crucial to monitor for BOM and ensure timely intervention if needed.

In conclusion, while POEM is an effective treatment for esophageal motility disorders, the potential for BOM underscores the importance of careful patient evaluation, procedural precision, and post-procedure monitoring.

Related Q&A

EndoBarrier Improves Diabetes and Weight Loss: Ann Surg | July 2026

Introduction: Endoscopic metabolic therapies have emerged as less invasive alternatives to bariatric surgery for patients with obesity and poorly controlled type 2 diabetes mellitus (T2DM). The EndoBarrier duodenal-jejunal bypass liner (DJBL) is an endoscopically placed...

Immediate Endoscopic Necrosectomy in Necrotizing Pancreatitis: Gastroenterology | July 2026

Introduction: Endoscopic ultrasound (EUS)-guided transmural drainage is the standard minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves...

Endoscopy After Bevacizumab Appears Safe: GIE | July 2026

Introduction: Bevacizumab is widely used in metastatic colorectal cancer (mCRC) because of its survival benefits but is associated with impaired wound healing, gastrointestinal perforation, and bleeding. These concerns often lead clinicians to delay endoscopic procedures...

Colorectal ESD Perforation: Endoscopy | July 2026

Introduction: Endoscopic submucosal dissection (ESD) enables en bloc resection of large colorectal neoplasms with excellent oncological outcomes. However, concerns about perforation have limited its widespread adoption. This large prospective multicenter study evaluated the incidence, risk...

Duodenal Mucosal Resurfacing REMAIN-1 Study: DDW | 2026

Introduction: Obesity has become one of the greatest global health challenges. New incretin-based therapies—including semaglutide, tirzepatide, resmetirom, and SGLT2 inhibitors such as empagliflozin—have transformed the treatment of obesity, diabetes, and MASLD. However, many patients discontinue...

EUS-FNAB for Solid Pancreatic Lesions: GIE | July 2026

Introduction: Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is the standard technique for diagnosing solid pancreatic lesions. Traditionally, biopsy specimens are processed for cytology, often requiring on-site cytopathology support. This multicenter prospective study evaluated whether directly placing...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer